These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36625437)

  • 1. MPET
    Wang H; Hu T; Leng Y; de Lucio M; Gomez H
    Drug Deliv; 2023 Dec; 30(1):2163003. PubMed ID: 36625437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiphysics Modeling and Simulation of Subcutaneous Injection and Absorption of Biotherapeutics: Model Development.
    Zheng F; Hou P; Corpstein CD; Xing L; Li T
    Pharm Res; 2021 Apr; 38(4):607-624. PubMed ID: 33811278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport and Lymphatic Uptake of Biotherapeutics Through Subcutaneous Injection.
    Han D; Rahimi E; Aramideh S; Ardekani AM
    J Pharm Sci; 2022 Mar; 111(3):752-768. PubMed ID: 34624293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport and lymphatic uptake of monoclonal antibodies after subcutaneous injection.
    Rahimi E; Aramideh S; Han D; Gomez H; Ardekani AM
    Microvasc Res; 2022 Jan; 139():104228. PubMed ID: 34547346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed-dimensional multi-scale poroelastic modeling of adipose tissue for subcutaneous injection.
    Leng Y; Wang H; de Lucio M; Gomez H
    Biomech Model Mechanobiol; 2022 Dec; 21(6):1825-1840. PubMed ID: 36057050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling large-volume subcutaneous injection of monoclonal antibodies with anisotropic porohyperelastic models and data-driven tissue layer geometries.
    de Lucio M; Leng Y; Hans A; Bilionis I; Brindise M; Ardekani AM; Vlachos PP; Gomez H
    J Mech Behav Biomed Mater; 2023 Feb; 138():105602. PubMed ID: 36529050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling drug transport and absorption in subcutaneous injection of monoclonal antibodies: Impact of tissue deformation, devices, and physiology.
    de Lucio M; Leng Y; Wang H; Vlachos PP; Gomez H
    Int J Pharm; 2024 Jul; ():124446. PubMed ID: 38996825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational modeling of the effect of skin pinch and stretch on subcutaneous injection of monoclonal antibodies using autoinjector devices.
    de Lucio M; Leng Y; Wang H; Ardekani AM; Vlachos PP; Shi G; Gomez H
    Biomech Model Mechanobiol; 2023 Dec; 22(6):1965-1982. PubMed ID: 37526775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the Monoclonal Antibody Disposition after Subcutaneous Administration using a Minimal Physiologically based Pharmacokinetic Model.
    Varkhede N; Forrest ML
    J Pharm Pharm Sci; 2018; 21(1s):130s-148s. PubMed ID: 30011390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport and distribution of biotherapeutics in different tissue layers after subcutaneous injection.
    Rahimi E; Gomez H; Ardekani AM
    Int J Pharm; 2022 Oct; 626():122125. PubMed ID: 35988855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiphysics Modeling and Simulation of Subcutaneous Injection and Absorption of Biotherapeutics: Sensitivity Analysis.
    Hou P; Zheng F; Corpstein CD; Xing L; Li T
    Pharm Res; 2021 Jun; 38(6):1011-1030. PubMed ID: 34080101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic uptake of biotherapeutics through a 3D hybrid discrete-continuum vessel network in the skin tissue.
    Han D; Li C; Araimdeh S; Sree V; Rahimi E; Buganza Tepole A; Ardekani AM
    J Control Release; 2023 Feb; 354():869-888. PubMed ID: 36634711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A compartment model for subcutaneous injection of monoclonal antibodies.
    Zhong X; Liu Y; Ardekani AM
    Int J Pharm; 2024 Jan; 650():123687. PubMed ID: 38103705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solute Transport across the Lymphatic Vasculature in a Soft Skin Tissue.
    Han D; Huang Z; Rahimi E; Ardekani AM
    Biology (Basel); 2023 Jun; 12(7):. PubMed ID: 37508373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal Antibody Pharmacokinetics in Cynomolgus Monkeys Following Subcutaneous Administration: Physiologically Based Model Predictions from Physiochemical Properties.
    Hu S; Datta-Mannan A; D'Argenio DZ
    AAPS J; 2022 Dec; 25(1):5. PubMed ID: 36456779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of physiochemical properties on the subcutaneous absorption and bioavailability of monoclonal antibodies.
    Datta-Mannan A; Estwick S; Zhou C; Choi H; Douglass NE; Witcher DR; Lu J; Beidler C; Millican R
    MAbs; 2020 Jan; 12(1):1770028. PubMed ID: 32486889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting monoclonal antibody pharmacokinetics following subcutaneous administration via whole-body physiologically-based modeling.
    Hu S; D'Argenio DZ
    J Pharmacokinet Pharmacodyn; 2020 Oct; 47(5):385-409. PubMed ID: 32500362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiphysics modeling and simulation of local transport and absorption kinetics of intramuscularly injected lipid nanoparticles.
    Di J; Hou P; Corpstein CD; Wu K; Xu Y; Li T
    J Control Release; 2023 Jul; 359():234-243. PubMed ID: 37295730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-scale numerical study of monoclonal antibodies uptake by initial lymphatics after subcutaneous injection.
    Li C; Zhong X; Rahimi E; Ardekani AM
    Int J Pharm; 2024 Jul; ():124419. PubMed ID: 38972522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of Clearance and Bioavailability of Therapeutic Monoclonal Antibodies from Only Subcutaneous Injection Data in Humans Based on Comprehensive Analysis of Clinical Data.
    Haraya K; Tachibana T
    Clin Pharmacokinet; 2021 Oct; 60(10):1325-1334. PubMed ID: 33954956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.